|
Zimbabwe
|
 |
 |
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
HIV prevalence 15-49, 2007/2008
15.3%
Tuberculosis death rate
151/100,000 population
Malaria death rate (children under 5)
0/100,000 population
|
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| |
|
|
| |
|
|
|
|
|
|
|
 |
|
| |
|
|
|
| |
Zimbabwe (formerly Rhodesia) is a Southern African country with an estimated population of about 13 million people. Until recently, Zimbabwe was one of the few countries in the region with a relatively improved infrastructure and stable economy. However, the HIV/AIDS epidemic, famine, and political instability threaten to engulf the country in a 'perfect storm' of political and economic disaster.
Currently, over one third of the adult population between 15-49 years is estimated to be HIV positive, and the epidemic is worsening. Only Botswana and Swaziland have higher infection rates. Despite the great impact of HIV/AIDS in Zimbabwe, and due to concerns about whether the funds would actually be used to benefit intended recipients, in the summer of 2004 the GFATM elected not to fund a $218 million Zimbabwean proposal to fight AIDS.
High unemployment (around 80 percent in mid-2004), fuel shortages, and nearly 7000 percent inflation - the world's highest - round out Zimbabwe's economic woes. While the HIV/AIDS epidemic and food shortages contribute to the bleak economic picture, political uncertainty and diplomatic isolation are important factors.
In March 2002 Mugabe and his party won elections that were widely criticized by western observers for violence, intimidation and other irregularities. Both British Prime Minister Tony Blair and US President George W. Bush have criticized Mugabe's rule, and have acted to diplomatically and economically isolate Zimbabwe. Fear that Mugabe's government will improperly spend funding has led many groups to delay or withdraw funding for HIV/AIDS in Zimbabwe.
Sources: BBC country profile; Synergy Project; AllAfrica.com, Inter Press Service (Johannesburg), June 3, 2004; AllAfrica.com, Zimbabwe Standard (Harare), July 26, 2004; AllAfrica.com, Daily HIV/AIDS report, August 12, 2004.
|
|
|
 |
|
|
|
|
|
|
|
 |
|
| |
|
|
|
|
|
|
|
| |
The Zimbabwean Ministry of Health and Child Welfare has a national health plan whose emphasis areas for the next five years include: HIV/AIDS, pulmonary TB control, malaria, and cholera. In addition, a National AIDS Coordination Programme (NACP) to coordinate AIDS activities and develop a National Policy on HIV/AIDS for Zimbabwe was officially launched in December, 1999. In early 2000, a National AIDS Council was established, with a mandate to strengthen the multi-sectoral response to HIV/AIDS. On January 1, 2000, the Zimbabwean government introduced an AIDS tax of 3 percent on money earned by individuals and corporations. The levy is expected to raise over US $25 million a year, and the revenues will go into a fund to buy low-cost generic drugs and address the needs of AIDS orphans. According to a 2003 Human Sciences Research Council (HSRC) report, Zimbabwe currently spends about 15.8% of government revenue on health care. This relatively high level of spending still results in only $43 per capita in health care spending each year.
Zimbabwe's President Robert Mugabe acknowledged that the cost of HIV/AIDS drugs as well as other hidden treatment/diagnosis costs are a huge problem. Addressing the country's first national AIDS conference in June of 2004, he said because the majority of Zimbabweans still rely on traditional medicine, it should complement modern medicine in the fight against HIV and AIDS.
Zimbabwe is a member state and partner of the Southern Africa Malaria Control Program. Zimbabwe has developed and revised national guidelines for malaria chemotherapy and chemoprophylaxis, and has drafted a national strategic plan for vector control.
TB treatment in Zimbabwe is provided by the public health sector without charge. DOTS population coverage is at 100% The DOTS detection rate in 2002 was 46 percent, and the treatment success rate for the 2001 cohort of DOTS TB patients was 81 percent. TB is grouped with HIV/AIDS in Zimbabwe's national health budget and an estimated two-thirs of adult TB cases were infected with HIV in 2002.
Sources: Synergy Project, HSRC report, Southern Africa Malaria Control Program, WHO Report 2004: Global Tuberculosis Control
|
|
|
 |
|
|
|
|
|
|
|
 |
|
| |
|
|
|
|
|
|
|
| |
| Total population. mid-2009 |
12.5 (millions) |
| HIV prevalence 15-49, 2007/2008
|
15.3% |
| Tuberculosis death rate |
151/100,000 population |
| Prevalence of tuberculosis per 100,000 population, 2000 |
650 |
| Prevalence of tuberculosis per 100,000 population, 2004 |
673 |
| % Tuberculosis detection rate under DOTS, 2001 |
45 |
| % Tuberculosis detection rate under DOTS, 2004 |
42 |
| % Tuberculosis treatment success rate under DOTS, 2000 |
69 |
| % Tuberculosis treatment success rate under DOTS, 2003 |
66 |
| Malaria death rate (children under 5) |
0/100,000 population |
| Life expectancy at birth |
41 years |
| Infant mortality rate |
60/1,000 live births |
| Total fertility rate |
3.8 per woman |
| Crude birth rate |
32/1,000 population |
| Crude death rate |
18/1,000 population |
| Adult male literacy level |
99% (pct. 15+ literate) |
| Adult female literacy level |
96% (pct. 15+ literate) |
| Contraceptive prevalence rate, modern methods |
58% of women in union |
| Estimated number of people living with HIV: Adults and Children, 2005 |
1,700,000 |
| Estimated number of people living with HIV: Adults and children, end 2003 |
1,800,000 |
| Estimated number of people living with HIV: Adults and children, end 2001 |
1,700,000 |
| Estimated number of people living with HIV: Adults (15+), 2005 |
1,500,000 |
| Estimated number of people living with HIV: Adults (15-49), end 2003 |
1,600,000 |
| Estimated number of people living with HIV: Adults (15-49), end 2001 |
1,600,000 |
| Estimated number of people living with HIV: Adults (15-49) rate (%), 2005 |
24.6% |
| Estimated number of people living with HIV: Adults (15-49) rate (%), 2003 |
24.9% |
| Estimated number of people living with HIV: Women (15+), 2005 |
890,000 |
| Estimated number of people living with HIV: Women 15-49, end 2003 |
930,000 |
| Estimated number of people living with HIV: Women 15-49, end 2001 |
900,000 |
| Estimated number of people living with HIV: Children (0-14), 2005 |
160,000 |
| Estimated number of people living with HIV: Children (0-14), end 2003 |
120,000 |
| Estimated number of people living with HIV: Children (0-14), end 2001 |
120,000 |
| Estimated number of AIDS deaths: Adults and children, 2005 |
180,000 |
| AIDS deaths in adults and children, end 2003
|
170,000 |
| AIDS deaths in adults and children, end 2001
|
160,000 |
| Estimated number of orphans due to AIDS: Children (0-17), 2005 |
1,100,000 |
| Orphans due to AIDS (0-17), living 2003
|
980,000 |
| Orphans due to AIDS (0-17), living 2001
|
830,000 |
| % Women (15-49), currently married or living with a partner, who have ever discussed AIDS prevention with their husband or partner |
60% |
Demographic data contained in this section was obtained from the following sources: The Population Reference Bureau’s 2009 World Population Data Sheet was used for total population, life expectancy at birth, infant mortality, fertility, birth rate, death rate, % of married women 15-49 using modern methods of contraception, % of population 15-49 with HIV/AIDS in 2007/2008, and the GNI PPP per capita (2008). Literacy rates were found in the Population Reference Bureau’s publication 2005 Women of Our World. HIV prevalence data for 2001 and 2003 was obtained from the UNAIDS Barcelona 2002 report; HIV prevalence and orphan data for 2005 was obtained from the UNAIDS Report on the Global AIDS Epidemic 2006. Data on the % women who have discussed AIDS prevention with their husband or partner can be found in ORC Macro and USAID’s Women’s Lives and Experiences: Changes in the Past Ten Years (Research Findings from the Demographic and Health Surveys). Childhood malaria mortality data was accessed in 2003 from the United Nations Statistics Divisions’ Millennium Indicators. Tuberculosis data was obtained from the United Nations Statistics Division’s Millennium Indicators: MDGInfo 2006. In some cases information was unavailable.
|
|
|
 |
|
|
|
|
|
|
|
 |
|
| |
|
|
|
|
|
|
|
| |
Zimbabwe has 10 provincial hospitals; the two most important hospitals are Parirenyatwa Hospital in Harare (900 beds) and Mpilo Central Hospital in Bulawayo (600 beds). The level of care currently available at Parirenyatwa Hospital is very rudimentary. According to a Zimbabwe Standard report, medicines are in short supply; basic medical equipment such as thermometers, IVs, wheelchairs, and blood-pressure cuffs are in short supply; and most of the hospital staff are out on strike, replaced by doctors and nurses of the Zimbabwe National Army.
In 1995 the WHO estimated that Zimbabwe had about 14 physicians and 129 nurses per 100,000 population. The economic and political situation in Zimbabwe has contributed to an exodus of trained medical personnel. Beginning in 2002 close to 200 Cuban health professionals began arriving in Zimbabwe in response to the resulting shortages, and the Democratic Republic of the Congo also sent about 80 health professionals. Zimbabwe has also taken the step of bonding nurses who have been trained in the country, requiring them to stay in the country.
Sources: AllAfrica.com, The Herald (Harare), November 13, 2003; AllAfrica.com, Zimbabwe Standard (Harare), January 5, 2004; AllAfrica.com, The Herald (Harare), May 31, 2004; NewAfrica.com; TravMed
|
|
|
 |
|
|
|
|
|
|
|
 |
|
| |
|
|
|
|
|
|
|
| |
The Bastirai Group (located in Chinhoyi) is conducting in two HIV-related studies. The first is a study of alternatives to breastfeeding, and the second a study of home-based care for persons terminally ill with AIDS. (Source: Scientists for Health and Research for Development (SHARED))
A regional center for biomedical research and training based in Harare, and serving the countries of the Southern Africa Development Community in the fields of biomedicine, epidemiology, laboratory technology, and health systems research. A list of research projects can be found at: Scientists for Health and Research for Development (SHARED)
Blair Research Institute comprises Blair Research Laboratory in Harare, and De Beers Research Laboratory located in Chiredzi. Blair Research Institute is Zimbabwe's national health science research center; its operations are overseen by the Ministry of Health and Child Welfare.
HIV, TB and malaria research is conducted by the Transmission and Vector Biology Unit (TVBU), directed by Dr. M. Chimbari. Currently the TVBU has 7 research officers, 22 support staff, and is conducting 9 research projects.
Chitungwiza Hospital, located in Chitungwiza, a suburb of Harare, is the site of two TB related research projects. One is a study of factors associated in the rise in TB cases in the local area. The second is an investigation of DOTS adherence in the area. (Source: Scientists for Health and Research for Development (SHARED))
According to the Afronets website, "The Medical Research Council of Zimbabwe is a specialised Council of the Research Council of Zimbabwe established in 1974 under the Research Act of 1959 to promote and co-ordinate all health research in Zimbabwe." The Director of Blair Research Institute is by law the Chair of the Medical Research Council of Zimbabwe.
Functions of the council include: - Reviewing research proposals
- Establishing institutional review boards at major research centers
- Organising workshops and specialised seminars that set priorities, and
- Acting as a network connecting researchers, program directors and policy-makers.
TARSC is a non-profit which runs a wide range of public health programs, including an HIV/AIDS and employment program.
Established in 1963, the University of Zimbabwe's Faculty of Medicine has for a long time been the only training center for medical doctors in the country. (It is unclear whether the College of Health Sciences at Bulawayo will be training medical doctors.) University of Zimbabwe researchers collaborate with a number of the US NIH-funded research projects in the country.
Bulawayo College of Health Sciences is a new institution in the University of Zimbabwe system. It offers a University of Zimbabwe MD (MBChb -Bachelor of Medicine and Bachelor of Surgery) degree. The US Fulbright Program is offering a grant for a medical sciences lectureship to begin in August, 2004. (Source: Fulbright Program)
|
|
|
 |
|
|
|
|
|
|
|
 |
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| NIH |
The Zimbabwe-San Francisco HIV Prevention Trials Unit |
HIV/AIDS |
Drug Development |
|
| |
(Principal Investigator: Tsungai Chipato. 2000-2005.) Investigators are conducting anti-retroviral clinical trials and research on rectal and...
|
| NIH |
Southern Africa-New York HIV Vaccine Trials Unit |
HIV/AIDS |
Drug Development |
|
| |
(PI: Glenda Gray. 2000-2004.) This project is conducting trials of the Alvac, AIDSVax, and gp160 vaccines in South Africa and Zimbabwe.
|
| NIH |
HIV Risk Reduction Through HSV-2 Prevention with N-9 |
HIV/AIDS |
Drug Development |
Prevention |
| |
(PI: Nancy Padian. 1999-2003.) This study examines the hypothesis that nonoxynol-9 microbicide can reduce HIV transmission by reducing the...
|
| NIH |
Acyclovir to Prevent HIV Acquisition in HSV-2 Positive Persons |
HIV/AIDS |
Drug Development |
|
| |
(PI: Connie Celum. 2002-2005.) Herpes Simplex Type 2 (HSV-2) has been shown in studies conducted in Uganda to increase susceptibility to HIV by a...
|
| NIH |
Immunopathogenesis of Acute HIV-1 Infection |
HIV/AIDS |
Drug Development |
Epidemiology |
| |
(PI: Robert Schooley. 2003-2008.) The University of Zimbabwe School of Medicine is one of four sites (the others are in Brazil and the US) providing...
|
| NIH |
Clinical Investigations |
HIV/AIDS |
Drug Development |
|
| |
(BENSON, CONSTANCE A. 2003-2008) This study will evaluate the immunologic, virologic, and clinical outcomes of potent therapy administered in the...
|
| NIH |
Clinical & Mucosal Interactions Between HSV & HIV |
HIV/AIDS |
Drug Development |
|
| |
(P.I. COREY, LAWRENCE 2003-2008) This project will measure the effect of clinical and subclinical HSV-2 reactivation on mucosal and systemic HIV-1...
|
| NIH |
Phase III Trial to Determine the Efficacy and Safety of an Extended Regimen of Nevirapine in Infants Born to HIV-Infected Women to Prevent Vertical HIV Transmission During Breastfeeding |
HIV/AIDS |
Drug Development |
Drug Development |
| |
(Study Chair: Hoosen Coovadia; PIs: Avinash K. Shetty, Rose Kambarami, Tsungai Chipato, Francis Mmiro, Karim Manji.) This 3.5 year study seeks to...
|
| NIH |
Phase II/IIb Safety and Effectiveness Study of the Vaginal Microbicides BuffeGel and 0.5% PRO 2000/5 Gel (P) for the Prevention of HIV Infection in Women |
HIV/AIDS |
Drug Development |
|
| |
(Study Chair: Salim Abdool Karim). 3220 participants in Malawi, South Africa, Tanzania, and Zimbabwe will be enrolled in this study designed to...
|
| NIH |
Once-Daily PI/NNRTI Therapy Combination for Treatment Naive, HIV Infected Patients in Resource-Limited Conditions |
HIV/AIDS |
Drug Development |
|
| |
(Study Chairs: Thomas B. Campbell, Timothy Flanigan, James Hakim, Nagalingeswaran Kumarasamy) This is a randomized trail with an expected...
|
| NIH |
International Studies of Acquired Immune Deficiency Syndrome |
HIV/AIDS |
Epidemiology |
|
| |
(PI: Thomas Quinn. 2003) A large study of HIV transmission including cohorts from Uganda, Congo, Zambia, Zimbabwe, South Africa, India, China and...
|
| NIH |
HIV-Related Oral Diseases Among Women in Harare |
HIV/AIDS |
Epidemiology |
|
| |
(PI: John Greenspan. 2002-2005.) Investigating oral mucosal lesions as an indicator of HIV disease progression, and the possibility of training...
|
| NIH |
HIV-1 p24 Based Viral Load Assay in Breast Milk and Serum |
HIV/AIDS |
Epidemiology |
Capacity |
| |
(PI: Andrzej Drukier. 1999-2003.) A project to develop an improved, low-cost assay for accurately detecting viral load in breast milk. The assay...
|
| NIH |
Genetics of TB: Cytokine Response and Iron |
HIV/AIDS,Tuberculosis |
Epidemiology |
|
| |
(PI: Leslie Louie. 2002-2003.) This study examines the relationship between iron metabolism and TB and HIV infections.
|
| NIH |
Randomized Trial of HIV/STI Prevention in Zimbabwe Youth |
HIV/AIDS |
Prevention |
|
| |
(PI: Frances Cowan. 2002-2007.) A cohort of 6,600 students over the age of 12 (median age of 15) in 30 Zimbabwean communities will take part in a...
|
| NIH |
Zimbabwe-Community Intervention to Reduce HIV/STD Risk |
HIV/AIDS |
Prevention |
|
| |
(PI: Danuta Kasprzyk. 2000-2004.) This project is identifying public opinion leaders in 16 communities and evaluating the effectiveness of HIV/STD...
|
| NIH |
A Randomized Trial of HIV Prevention in Harare Beerhalls |
HIV/AIDS |
Prevention |
|
| |
(PI: Katherine Fritz. 2002-2007.) This is a study of a culturally specific behavior change project aimed at reducing transmission of HIV by men...
|
| NIH |
Economic Opportunity for Zimbabwean Adolescent Orphans |
HIV/AIDS |
Prevention |
|
| |
(PI: Nancy Padian. 2003-2008.) Nancy Padian of the University of California San Francisco is leading this study of the role of economic opportunites...
|
| NIH |
Community-Based HIV VCT: Zimbabwe |
HIV/AIDS |
Prevention |
|
| |
(PI: Stephen Morin. 2003-2008.) Stephen Morin is directing the Zimbabwean component of a randomized trial comparing community -based VCT to clinic...
|
| NIH |
African Program for Training in HIV/TB Research |
HIV/AIDS,Tuberculosis |
Capacity |
|
| |
(PI: Peter Mason. 2002-2003.) This grant supports the development of training courses in HIV and TB research at the University of Zimbabwe. The...
|
| NIH |
ARV Therapy for MCTH Prevention & Treatment in Zimbabwe |
HIV/AIDS |
Capacity |
Drug Development,Prevention |
| |
(PI: Lynn Zijenah. 2002-2003.) The purpose of this grant is to organize a research group and establish the necessary infrastructure in Zimbabwe to...
|
| NIH |
Malaria Research and Training Program in Zimbabwe (MRTPZ) |
Malaria |
Capacity |
|
| |
(PI: Nirbhay Kumar. 2000-2005.) MRTPZ is a collaborative undertaking of the Johns Hopkins School of Public Health, the Blair Research Institute...
|
| NIH |
Long-Term Follow-Up of HIV Infected Patients Identified During Early Infection |
HIV/AIDS |
General |
|
| |
National Institute of Allergy and Infectious Diseases (Study Chairs: Martin Markowitz, Susan Little). This multi-site trial (U.S., Australia,...
|
| Other US |
United States |
HIV/AIDS |
Epidemiology |
|
| |
The United States government has donated antiretroviral (ARV) drugs worth over US $500,000 to Zimbabwe's health ministry.
Source: AllAfrica.com
|
| Other US |
CDC |
HIV/AIDS |
General |
|
| |
In Zimbabwe, the CDC Global AIDS Program in collaboration with the government and other donors is conducting activities in HIV/AIDS prevention, care...
|
| Other US |
USAID |
HIV/AIDS |
General |
|
| |
One of USAID's major objectives is to support efforts to mitigate the impact of the HIV/AIDS crisis in Zimbabwe. To achieve this objective USAID...
|
| International |
Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptoccal Meningitis in Africa |
HIV/AIDS |
Drug Development |
General |
| |
University of Zimbabwe; AIDS Care Research Institute in Africa (Study Chair: James Hakim; PIs: Chiratidzo Ndhlovu, Azure Makadzange). This study...
|
| International |
A Pilot Study of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe |
HIV/AIDS |
Drug Development |
|
| |
Parirenyatwa Hospital, University of Colorado at Denver and Health Sciences Center, GlaxoSmithKline, Abbott, and University of Zimbabwe College of...
|
| International |
Europe-Africa Research Network for Evaluation of Second-Line Therapy (EARNEST) |
HIV/AIDS |
Drug Development |
General |
| |
European and Developing Countries Clinical Trials Parntership; the University of Malawi; in Uganda, the Joint Clinical Research Centre, Infectious...
|
| International |
Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) |
HIV/AIDS |
General |
|
| |
In February of 2003, the GFATM signed a $6.7 million grant agreement with Zimbabwe to help fight malaria in that country. Through the end of 2003...
|
| International |
World Bank |
HIV/AIDS |
General |
|
| |
The $60 million World Bank funded Multi-Sectoral HIV/AIDS project provides support over a five-year period to scale up and accelerate Zimbabwe's...
|
| International |
Norway (NORAD) |
HIV/AIDS |
General |
|
| |
The Norwegian Government through NORAD is providing support to Zimbabwe in HIV/AIDS and other health-related projects
|
| International |
World Health Organization |
Malaria |
General |
|
| |
In April 2003 the World Health Organization donated to Zimbabwe approximately $48 million worth of anti-malarial drugs and merchandise promoting an...
|
| NGO |
Medecins Sans Frontieres |
HIV/AIDS |
Drug Development |
|
| |
A Spanish-speaking branch of MSF is active in Zimbabwe, and plays a critical role in distributing ARVs to patients with HIV in Bulawayo. MSF...
|
| NGO |
International Red Cross and Red Crescent |
HIV/AIDS |
General |
|
| |
The Danish Red Cross supports HIV/AIDS work in Zimbabwe.
|
| Foundation |
Wellcome Trust Tuberculosis Study |
Tuberculosis |
Epidemiology |
|
| |
The Wellcome Trust is funding a large study of M. tuberculosis strains in Zimbabwe and South Africa. V. Chihota is the study coordinator, and...
|
| Foundation |
Elizabeth Glaeser Pediatric AIDS Foundation |
HIV/AIDS |
Prevention |
Drug Development |
| |
The Elizabeth Glaeser Pediatric AIDS Foundation is funding an MTCT prevention study based on use of a short course of the nevirapine ART and...
|
| Foundation |
Gates Foundation. The Latex Diaphragm to Prevent HIV Acquisition Among Women: A Female-Controlled Physical Barrier of the Cervix. |
HIV/AIDS |
Prevention |
|
| |
(PI: Nancy Padian; 2003-2007). 4500 women currently HIV-negative will be enrolled in this study to determine whether the use of a diaphragm and...
|
| Foundation |
Gates Foundation |
HIV/AIDS |
General |
|
| |
With support from the Bill and Melinda Gates Foundation, Africare is strengthening and...
|
|
|
|
 |
|
|
|
|
|
|
|
 |
|
| |
|
|
|
|
|
|
|
| |
No information available
|
|
|
 |
|
|
|
|
|
|
|